Potential link between alcohol, breast cancer identified
Washington: Researchers have identified a protein that may finally explain the association between alcohol consumption and breast cancer.
Alcohol consumption has long been established as a risk factor for breast cancer. But finding the direct link has so far proved elusive.
“Cells have different mechanisms to remove toxic substances, such as ethanol, the chemical name for alcohol, that represent a potential risk to them,” explained María de Lourdes Rodríguez-Fragoso, professor of pharmacology and toxicology at the Universidad Autonoma del Estado de Morelos in Mexico.
“Unfortunately, sometimes these mechanisms produce other toxic substances, including some that are associated with the development of different types of cancer.”
Now, Rodríguez-Fragoso and her collaborators think that they have found the answer, a protein called CYP2E1.
“We knew that CYP2E1 could break down ethanol and that doing so created unstable, highly reactive chemicals known as free radicals,” she said.
Working with researcher Scott Burchiel and his group at the University of New Mexico, Rodriguez-Fragoso’s team had previously found that free radicals were associated with activation of cellular mechanisms that lead to tumour development.
“The question then was, does having more CYP2E1 make you more susceptible to ethanol-induced toxicity, thereby increasing your risk of developing cancer?”
CYP2E1 is found in breast cells known as mammary epithelial cells, which are also where most breast cancers originate, suggesting to the researchers that CYP2E1 may be involved in breast cancer development.
To test this hypothesis, the researchers administered ethanol to separate cultures of mammary epithelial cells that had varying levels of CYP2E1.
Cells that expressed low levels of CYP2E1 were mostly immune to the effects of the ethanol treatment; however, cells with increased amounts of CYP2E1 protein were greatly affected, suggesting that women with higher expression levels of the protein would show similar responses.
Significantly, points out Rodríguez-Fragoso, “our results showed that ethanol-treated human mammary cells had an increase in free radical production, oxidative stress and the activation of cellular mechanisms that cause cells to increase their proliferation rate,” all hallmarks of cancer.
“So if you are a woman who naturally expresses higher levels of CYP2E1 and you consume alcohol, you would be at a greater risk for developing breast cancer than a woman who expresses lower amounts of CYP2E1,” she explained.
A few months ago, the group started investigating CYP2E1 expression levels in breast tissue obtained from healthy women who had undergone mammaplasties.
“Preliminary results show that there is great variability in the expression of this enzyme among the analyzed samples,” said Rodriguez-Fragoso.
“This means that each individual will have a different response to alcohol, and each should take different precautions to minimize their risk of developing breast cancer.”
With these results in hand, Rodríguez-Fragoso expressed confidence that her group will be able to develop a method of diagnosis that would focus on the determination of expression levels of CYP2E1 in breast tissue.
“If you know the risk probability of certain behaviors on your likelihood of developing cancer, then you can better understand what preventative measures you should be taking,” she emphasized.
“If we can prevent the development of breast cancer associated with alcohol intake by timely diagnoses of markers such as CYP2E1,” added Rodríguez-Fragoso, “then the annual numbers of new cases and deaths could be diminished significantly.”